Nuvation Bio Balance Sheet Health
Financial Health criteria checks 5/6
Nuvation Bio has a total shareholder equity of $502.7M and total debt of $8.4M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are $571.6M and $68.9M respectively.
Key information
1.7%
Debt to equity ratio
US$8.43m
Debt
Interest coverage ratio | n/a |
Cash | US$549.14m |
Equity | US$502.71m |
Total liabilities | US$68.87m |
Total assets | US$571.58m |
Recent financial health updates
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way?
Nov 20Is Nuvation Bio (NYSE:NUVB) A Risky Investment?
Aug 07We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Sep 14We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely
Feb 10We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Nov 09Recent updates
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way?
Nov 20Nuvation Bio: Competitive Data In ROS1+ NSCLC, Strong Cash, Smallish Market
Oct 21Nuvation Bio: Continuing To Justify A Buy Thesis With Catalysts In 2024
Aug 08Is Nuvation Bio (NYSE:NUVB) A Risky Investment?
Aug 07Nuvation Bio: A Potentially Transformative Acquisition
Jun 20Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate
Mar 31Nuvation: Cash Is King, Science Is An Afterthought
Oct 03We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Sep 14Seth Klarman's Baupost adds Herbalife, Altice USA, exits Dropbox, Enhabit
Feb 14We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely
Feb 10We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Nov 09Nuvation Bio GAAP EPS of -$0.12 beats by $0.02
Nov 03Financial Position Analysis
Short Term Liabilities: NUVB's short term assets ($565.0M) exceed its short term liabilities ($59.0M).
Long Term Liabilities: NUVB's short term assets ($565.0M) exceed its long term liabilities ($9.8M).
Debt to Equity History and Analysis
Debt Level: NUVB has more cash than its total debt.
Reducing Debt: NUVB's debt to equity ratio has increased from 0.2% to 1.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NUVB has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: NUVB has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 23.8% each year